Vitruviae
1 known investors
VITRUVIAE is a biotechnology company developing cancer immunotherapies that target sugars and lipids found on tumor cells but not on healthy cells, aiming to improve tumor selectivity and counter drug resistance. Its dual sugar-lipid targeting platform is engineered into formats such as T-cell engagers, CAR immune cells, and radioactive delivery platforms, with a lead program (VTRU200) for acute myeloid leukemia.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Vitruviae do?
- VITRUVIAE is a biotechnology company developing cancer immunotherapies that target sugars and lipids found on tumor cells but not on healthy cells, aiming to improve tumor selectivity and counter drug resistance. Its dual sugar-lipid targeting platform is engineered into formats such as T-cell engagers, CAR immune cells, and radioactive delivery platforms, with a lead program (VTRU200) for acute myeloid leukemia.
- Who founded Vitruviae?
- Vitruviae was founded by Sonia Sequeira.
- Who are Vitruviae's investors?
- Vitruviae's investors include Angel Physicians Fund.